Stay updated with breaking news from 91307c10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
United Therapeutics Co. (NASDAQ:UTHR – Get Rating) Director Nilda Mesa sold 374 shares of the business’s stock in a transaction on Friday, May 5th. The shares were sold at an average price of $214.81, for a total transaction of $80,338.94. Following the sale, the director now directly owns 5,806 shares in the company, valued at […]
United Therapeutics (NASDAQ:UTHR – Get Rating) issued its quarterly earnings results on Wednesday. The biotechnology company reported $4.86 EPS for the quarter, beating analysts’ consensus estimates of $4.26 by $0.60, Briefing.com reports. The business had revenue of $506.90 million for the quarter, compared to analysts’ expectations of $514.37 million. United Therapeutics had a net margin […]
Texas Permanent School Fund lessened its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 6.4% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 30,641 shares of the biotechnology company’s stock after selling 2,096 shares during the period. Texas Permanent School Fund owned […]
United Therapeutics (NASDAQ:UTHR – Get Rating) issued its quarterly earnings results on Wednesday. The biotechnology company reported $4.86 EPS for the quarter, beating analysts’ consensus estimates of $4.26 by $0.60, Briefing.com reports. The firm had revenue of $506.90 million during the quarter, compared to the consensus estimate of $514.37 million. United Therapeutics had a return […]
United Therapeutics (NASDAQ:UTHR – Get Rating) released its quarterly earnings data on Wednesday. The biotechnology company reported $4.86 EPS for the quarter, beating the consensus estimate of $4.26 by $0.60, Briefing.com reports. The business had revenue of $506.90 million for the quarter, compared to the consensus estimate of $514.37 million. United Therapeutics had a net […]